RA patients on upadacitinib and methotrexate showed robust antibody and T-cell responses to the recombinant zoster vaccine over 60 weeks. The vaccine maintained a satisfactory humoral response in 71.4 ...
Scientists led by Stephanie Eisenbarth, MD, Ph.D., the Roy and Elaine Patterson Professor of Medicine and director of the ...
While mRNA vaccines trigger potent initial immune responses, emerging data suggest they do not generate durable plasma cells, ...
"Our goal was to create a human system that captures how the liver and immune system interact in patients," El Abdellaoui Soussi says. "By integrating patient-specific genetics and immune responses, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback